#1 Clinical Trials Search in Europe

Prednisone

Prednisone, a widely used corticosteroid medication, has been the subject of numerous clinical trials exploring its effectiveness in treating various conditions. This article examines recent studies investigating prednisone’s use in managing diseases such as asthma, lupus, rheumatoid arthritis, heart failure, and chronic obstructive pulmonary disease (COPD). We’ll look at different formulations, dosages, and potential benefits of prednisone across these diverse medical applications.

Table of Contents

What is Prednisone?

Prednisone is a medication that belongs to a class of drugs called corticosteroids or glucocorticoids. It is a synthetic version of cortisol, a hormone naturally produced by the adrenal glands in your body. Prednisone is widely used for its powerful anti-inflammatory and immunosuppressive properties[1].

This medication is available under various brand names, including Cortancyl and Decortin H. It’s important to note that prednisone is different from prednisolone, which is another corticosteroid medication[2][3].

Conditions Treated with Prednisone

Prednisone is used to treat a wide range of conditions, including:

  • Rheumatoid Arthritis (RA): A chronic inflammatory disorder affecting the joints[1]
  • Systemic Lupus Erythematosus (SLE): An autoimmune disease that can affect various parts of the body[4]
  • Multiple Myeloma: A type of blood cancer that affects plasma cells[5][6]
  • Asthma: A condition that affects the airways and causes breathing difficulties[3]
  • Calcium Pyrophosphate Deposition (CPPD) Arthritis: Also known as pseudogout, a type of arthritis caused by crystal deposits in the joints[2]
  • Achalasia: A rare disorder of the esophagus that makes it difficult to swallow food[7]

How Prednisone Works

Prednisone works by mimicking the effects of cortisol in your body. It reduces inflammation and suppresses the immune system, which can help alleviate symptoms in various conditions[1].

In conditions like rheumatoid arthritis, prednisone helps reduce joint pain, swelling, and stiffness. For asthma patients, it can help reduce airway inflammation and improve breathing[3].

In blood cancers like multiple myeloma, prednisone is often used in combination with other drugs to help kill cancer cells and reduce inflammation[5].

Dosage Forms and Administration

Prednisone is available in several forms:

  • Oral tablets: These come in various strengths, typically ranging from 1 mg to 20 mg[2]
  • Modified-release tablets: These are designed to release the medication at specific times, which can be helpful for conditions with symptoms that worsen at night or early morning[3]

The dosage and duration of treatment can vary greatly depending on the condition being treated and the individual patient’s response. For example:

  • For rheumatoid arthritis, doses may range from 5 mg to 10 mg daily[1]
  • For acute CPPD arthritis, a dose of 20 mg daily might be used[2]
  • In multiple myeloma treatment, prednisone might be given at 60 mg/m² for 4 days as part of a combination therapy[5]

It’s crucial to follow your doctor’s instructions carefully when taking prednisone. Never stop taking the medication abruptly without medical supervision, as this can lead to withdrawal symptoms.

Potential Side Effects

While prednisone can be very effective, it can also cause side effects, especially when used at higher doses or for long periods. Some potential side effects include[2]:

  • Gastrointestinal issues: Nausea, vomiting, abdominal pain
  • Increased blood sugar levels
  • Sleep disturbances
  • Mood changes or irritability
  • Increased blood pressure
  • Changes in kidney function

Long-term use of prednisone may lead to more serious side effects, such as osteoporosis, increased risk of infections, and adrenal suppression. Your doctor will monitor you closely for these potential effects[1].

Ongoing Research and Clinical Trials

Researchers continue to study prednisone to better understand its effects and explore new uses. Some areas of ongoing research include:

  • Comparing prednisone to other treatments for various conditions, such as colchicine for CPPD arthritis[2]
  • Investigating modified-release formulations of prednisone for better management of nocturnal asthma symptoms[3]
  • Studying the effectiveness of prednisone in combination with other drugs for multiple myeloma treatment[8]
  • Exploring the use of prednisone in treating fatigue associated with systemic lupus erythematosus[4]

These ongoing studies aim to improve our understanding of prednisone and optimize its use in various medical conditions.

Condition Prednisone Formulation Key Findings/Objectives
Nocturnal Asthma Modified-release (Lodotra) Evaluated efficacy on nocturnal symptoms compared to immediate-release prednisone
Lupus Delayed-release (RAYOS) Compared effect on fatigue to immediate-release prednisone
Rheumatoid Arthritis Delayed-release (RAYOS) Assessed effectiveness on disease activity and morning stiffness
Heart Failure Standard prednisone Examined efficacy of different doses (15, 30, 60 mg/day) on diuresis
COPD Standard prednisone Studied effect on gene expression in stable COPD patients
Chondrocalcinosis (CPPD) Standard prednisone Compared efficacy and safety to colchicine for acute CPPD arthritis

FAQ

  • What conditions is prednisone being studied for in clinical trials? Recent clinical trials have explored prednisone's use in treating asthma, lupus, rheumatoid arthritis, heart failure, and chronic obstructive pulmonary disease (COPD).
  • Are there different formulations of prednisone being tested? Yes, studies have compared modified-release prednisone (like Lodotra or RAYOS) to immediate-release prednisone to assess their effectiveness in managing symptoms at different times of day.
  • How is prednisone's effectiveness measured in these trials? Effectiveness is measured through various means, including changes in disease activity scores, patient-reported symptoms, laboratory tests, and functional assessments specific to each condition being studied.
  • What are some potential benefits of prednisone being investigated? Potential benefits being studied include improved control of nocturnal asthma symptoms, reduced fatigue in lupus patients, better management of rheumatoid arthritis symptoms, enhanced diuresis in heart failure, and effects on gene expression in COPD.
  • Are there any comparisons being made between prednisone and other treatments? Some trials compare prednisone to other medications or treatment approaches. For example, one study compared colchicine to prednisone for treating acute calcium pyrophosphate deposition (CPPD) arthritis.

Ongoing Clinical Trials on Prednisone

  • A study testing prednisone combined with antibiotics compared to antibiotics alone in adults with septic arthritis to improve joint health

    Recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    France

  • Title: Evaluating low-dose prednisone with standard therapy to improve heart function in patients with cardiac manifestations of Fabry disease

    Recruiting

    3 1 1 1
    Investigated drugs:
    Poland

  • Study of ALXN2350 gene therapy in adults with BAG3 mutation-associated dilated cardiomyopathy: A safety and efficacy trial

    Recruiting

    2 1 1 1
    Investigated drugs:
    Germany Italy Spain

  • Study of Blinatumomab and a drug combination for older adults with newly diagnosed Philadelphia-negative B-cell precursor Acute Lymphoblastic Leukemia

    Recruiting

    3 1 1 1
    Investigated drugs:
    Austria Belgium Bulgaria Czechia Denmark Estonia +11

  • A study of JNJ-78278343 and docetaxel compared to docetaxel and prednisone in patients with metastatic castration-resistant prostate cancer

    Recruiting

    3 1 1 1
    Investigated drugs:
    Belgium France Germany Italy Spain

  • Study of AMO959, lutetium (177Lu) vipivotide tetraxetan, and a drug combination for adults with advanced prostate cancer.

    Recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    France Germany Italy Spain

  • A study comparing AZD0486 after reduced chemotherapy versus standard chemotherapy in older or unfit patients with newly diagnosed large B-cell lymphoma

    Recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium Poland

  • A study comparing odronextamab combined with chemotherapy versus rituximab combined with chemotherapy in adults with previously untreated follicular lymphoma

    Recruiting

    3 1 1 1
    Investigated drugs:
    Austria Belgium Czechia France Germany Italy +2

  • Testing avacopan added to standard treatment in patients with ANCA-associated vasculitis with severe kidney damage

    Recruiting

    3 1 1
    Investigated drugs:
    France

  • A study testing ASP5541 compared to abiraterone acetate in patients with advanced prostate cancer

    Recruiting

    2 1 1 1
    Investigated drugs:
    France Germany Italy Poland Spain

Glossary

  • Prednisone: A corticosteroid medication used to treat various inflammatory conditions and autoimmune disorders.
  • Modified-release prednisone: A formulation of prednisone designed to release the medication at specific times, such as during the night, to better manage symptoms.
  • RAYOS: A brand name for delayed-release prednisone, used in some clinical trials for conditions like rheumatoid arthritis and lupus.
  • Lodotra: Another brand name for modified-release prednisone, studied for use in conditions like nocturnal asthma.
  • DAS28: Disease Activity Score in 28 Joints, a measure used to assess the activity of rheumatoid arthritis in clinical trials.
  • FACIT-F: Functional Assessment of Chronic Illness Therapy-Fatigue, a tool used to measure fatigue in patients with chronic illnesses like lupus.
  • Acute exacerbation of COPD (AECOPD): A sudden worsening of COPD symptoms that often requires additional treatment or hospitalization.
  • Chondrocalcinosis: Also known as calcium pyrophosphate deposition (CPPD) disease, a condition where calcium crystals form in joint cartilage, causing arthritis-like symptoms.
  • Diuresis: Increased production of urine, often a goal in treating heart failure to reduce fluid overload.
  • Gene expression: The process by which information from a gene is used to create a functional gene product, often a protein.

References

  1. https://clinicaltrials.gov/study/NCT01393639
  2. https://clinicaltrials.gov/study/NCT03128905
  3. https://clinicaltrials.gov/study/NCT00686335
  4. https://clinicaltrials.gov/study/NCT03098823
  5. https://clinicaltrials.gov/study/NCT01063179
  6. https://clinicaltrials.gov/study/NCT00551928
  7. https://clinicaltrials.gov/study/NCT01903486
  8. https://clinicaltrials.eu/trial/study-comparing-bortezomib-melphalan-prednisone-lenalidomide-and-daratumumab-for-multiple-myeloma-in-patients-ineligible-for-stem-cell-transplant/